Articles Luxor Scientific and Capstone Health Alliance Forge Partnership Luxor Scientific and Capstone Health Alliance Forge Partnership Introducing Advanced Diagnostic Testing to Health Systems…mlipumaAugust 6, 2024
Blog Luxor Scientific’s head scientists team up with other industry leaders to evaluate the new Roche benzodiazepine II assay to determine clinical sensitivity. mlipumaJune 28, 2024
Articles Luxor Scientific Unveils Cutting-Edge Testing Solutions to Combat Escalating Illicit Drug Crisis Luxor Scientific Unveils Cutting-Edge Testing Solutions to Combat Escalating Illicit Drug Crisis Greenville, SC June…mlipumaJune 25, 2024
Articles CIMA Sciences, In Partnership with Luxor Scientific Launches Revolutionary Liver Disease Test CIMA Sciences, in Partnership with Luxor Scientific Launches Revolutionary Liver Disease Test Recent advancements signify…mlipumaMay 15, 2024
Articles Orchard Software Partners with Luxor Scientific to Expand Testing Services Orchard Software Partners with Luxor Scientific to Expand Testing Services CARMEL, Ind., May 8, 2024 /PRNewswire/ -- Orchard…mlipumaMay 8, 2024
Articles Scientists Develop Proprietary Technology Scientists Develop Proprietary Technology Addressing Issues on the Rise with Unregulated CBD- and Delta-8-THC based…mlipumaApril 18, 2024
Blog Xylazine: An Emerging Threat to Addiction Professionals of North Carolina Luxor Scientific leadership on Xylazine As fentanyl use and abuse in the US continues to…mlipumaFebruary 15, 2024
Blog Luxor Scientific’s Chief Science Officer, Dr. Marion Snyder, joins other industry leaders to publish abstract mlipumaJuly 1, 2023